Genentech Archives

Tag: Genentech

LRA Forum for Discovery Showcases Cutting-Edge Lupus Research

December 11, 2024. The Lupus Research Alliance (LRA) hosted its highly anticipated annual scientific conference, Forum for Discovery (FFD), November 11-13 in New York City. A hallmark event for the lupus research community, FFD brings together LRA-funded investigators from across the globe to discuss the latest breakthroughs of their LRA-funded projects. Serving as a crucial […] Read More

Gazyva® Shows Positive Results in Phase 3 Lupus Nephritis Trial

NEW YORK, NY, September 25, 2024 — The Lupus Research Alliance (LRA) and clinical research affiliate Lupus Therapeutics (LT) are excited to share positive news of the Phase 3 REGENCY clinical trial showing benefits of Gazyva® (obinutuzumab) in treating people with active lupus nephritis (inflammation of the kidney associated with lupus). In development as a potential treatment […] Read More

Breadth of Clinical Research Presented at the 2019 ACR/ARP Annual Meeting Brings Hope for New Lupus Treatments

November 14, 2019 The Lupus Research Alliance staff was on the ground at the 2019 ACR/ARP Annual Meeting and highly encouraged by the positive results reported for several potential new treatments that may help people with lupus. “The foundational work the Lupus Research Alliance and others have supported is beginning to bear fruit with potential […] Read More

Lupus Research Alliance Response to Positive Trial Testing Obinutuzumab (Gazyva®) for Lupus Nephritis

NEW YORK, Nov. 10, 2019 /PRNewswire/ — The Lupus Research Alliance (LRA) is pleased to acknowledge positive results presented by Genentech at the American Society of Nephrology (ASN) and the 2019 ACR/ARP Annual Meeting showing the effectiveness of obinutuzumab (Gazyva®), a type I anti-CD20 monoclonal antibody, in the Phase 2 NOBILITY trial for the most severe […] Read More

Multi-ethnic Study Identifies New Genetic Markers for Lupus

Scientists from an international consortium have identified a large number of new genetic markers that predispose individuals to lupus. The study is published in the July 17 issue of the journal Nature Communications and was led by researchers at Wake Forest Baptist Medical Center, Oklahoma Medical Research Foundation, King’s College of London and Genentech Inc. Autoimmune diseases […] Read More